In human invasive breast ductal carcinoma, tumor stromal macrophages and tumor nest macrophages have distinct relationships with clinicopathological parameters and tumor angiogenesis

Virchows Archiv

Volumn 462, Issue 3, 2013, Pages 257-267

  Ch'Ng, Ewe Seng ^a   Tuan Sharif, Sharifah Emilia ^a   Jaafar, Hasnan ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Breast cancer; Microvessel density; Tumor angiogenesis; Tumor stroma; Tumor associated macrophages

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER GRADING; CANCER SIZE; CAPILLARY DENSITY; CARCINOGENESIS; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; SCORING SYSTEM; STROMA CELL; TUMOR ASSOCIATED LEUKOCYTE; BREAST TUMOR; IMMUNOLOGY; MACROPHAGE; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PAGET NIPPLE DISEASE; PATHOLOGY; TUMOR MICROENVIRONMENT; VASCULARIZATION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MIDDLE AGED; NEOPLASM GRADING; NEOVASCULARIZATION, PATHOLOGIC; TUMOR MICROENVIRONMENT;

MLCS; MLOWN;

EID: 84876093272     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1362-4     Document Type: Article

References (41)

1. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539-545
2. Murri AMA, Hilmy M, Bell J, Wilson C, McNicol AM, Lannigan A, Doughty JC, McMillan DC (2008) The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer. Br J Cancer 99(7):1013-1019
3. Pupa SM, Bufalino R, Invernizzi AM, Andreola S, Rilke F, Lombardi L, Colnaghi MI, Menard S (1996) Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas. J Clin Oncol 14(1):85-94
4. Lewis CE, Leek R, Harris A, McGee JO (1995) Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol 57(5):747-751
5. Lin EY, Nguyen AV, Russell RG, Pollard JW (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193(6):727-740
6. Goswami S, Sahai E, Wyckoff JB, Cammer M, Cox D, Pixley FJ, Stanley ER, Segall JE, Condeelis JS (2005) Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 65(12):5278-5283
7. Hagemann T, Robinson SC, Schulz M, Trumper L, Balkwill FR, Binder C (2004) Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 25(8):1543-1549
8. Volodko N, Reiner A, Rudas M, Jakesz R (1998) Tumour-associated macrophages in breast cancer and their prognostic correlations. Breast 7(2):99-105
9. Valkovic T, Dobrila F, Melato M, Sasso F, Rizzardi C, Jonjic N (2002) Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma. Virchows Arch 440(6):583-588
10. Jonjic N, Valkovic T, Lucin K, Iternicka Z, Krstulja M, Mustac E, Dobi-Babic R, Sasso F, Melato M (1998) Comparison of microvessel density with tumor associated macrophages in invasive breast carcinoma. Anticancer Res 18(5B):3767-3770
11. Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S (2005) Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 14(2):425-431
12. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56(20):4625-4629
13. Valentin G, Laura B, Marina Z, Hellmut GA (1999) Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 82(5):765-770
14. Bolat F, Kayaselcuk F, Nursal TZ, Yagmurdur MC, Bal N, Demirhan B (2006) Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters. J Exp Clin Cancer Res 25(3):365-372
15. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C (1994) Macrophages and angiogenesis. J Leukoc Biol 55(3):410-422
16. Crowther M, Brown NJ, Bishop ET, Lewis CE (2001) Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol 70(4):478-490
17. Craig M, Claire EL (2005) Macrophage migration and gene expression in response to tumor hypoxia. Int J Cancer 117(5):701-708
18. Lin EY, Li J-F, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, Qian H, Pollard JW (2006) Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 66(23):11238-11246
19. Ch'ng ES, Jaafar H, Tuan Sharif SE (2011) Breast tumor angiogenesis and tumor-associated macrophages: histopathologist's perspective. Patholog Res Int 2011(2011):572706
20. Valkovic T, Fuckar D, Stifter S, Matusan K, Hasan M, Dobrila F, Jonjic N (2005) Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma. J Cancer Res Clin Oncol 131(7):453-458
21. Lee AH, Happerfield LC, Bobrow LG, Millis RR (1997) Angiogenesis and inflammation in invasive carcinoma of the breast. J Clin Pathol 50(8):669-673
22. Leek RD, Landers RJ, Harris AL, Lewis CE (1999) Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 79(5-6):991-995
23. Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, Koike M, Inadera H, Matsushima K (2000) Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6(8):3282-3289
24. Leek RD, Hunt NC, Landers RJ, Lewis CE, Royds JA, Harris AL (2000) Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 190(4):430-436
25. Hisashi S, Morio K, Takao Y, Shigehira S, Motoharu S, Kouji M, Masakazu T (2001) Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer 92(5):1085-1091
26. Lewis JS, Landers RJ, Underwood JCE, Harris AL, Lewis CE (2000) Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J Pathol 192(2):150-158
27. Hiroshi F, Takafumi S, Genichiro I, Akashi I, Takeshi N, Masaru M, Atsushi O (2009) Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. Int J Cancer 125(6):1276-1284
28. Vicioso L, Gonzalez FJ, Alvarez M, Ribelles N, Molina M, Marquez A, Perez L, Matilla A, Alba E (2006) Elevated serum levels of vascular endothelial growth factor are associated with tumor-associated macrophages in primary breast cancer. Am J Clin Pathol 125(1):111-118
29. Ohno S, Inagawa H, Soma G, Nagasue N (2002) Role of tumor-associated macrophage in malignant tumors: should the location of the infiltrated macrophages be taken into account during evaluation? Anticancer Res 22(6C):4269-4275
30. Elston CW, Ellis IO (1991) pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403-410
31. Dako (2010) HercepTest™ interpretation manual - breast.
32. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324(1):1-8
33. Fox SB (2006) Quantitative angiogenesis in breast cancer. In: Brooks SA, Harris A (eds) Breast cancer research protocols. Methods in molecular medicine. Humana Press, Totowa, NJ, pp 161-187
34. Ch'ng ES, Tuan Sharif SE, Jaafar H (2012) Characteristics of invasive breast ductal carcinoma, NOS, diagnosed in a tertiary institution in the East Coast of Malaysia with a focus on tumor angiogenesis. Asian Pac J Cancer Prev 13(9):4445-4452
35. Ribatti D, Nico B, Crivellato E, Vacca A (2007) Macrophages and tumor angiogenesis. Leukemia 21(10):2085-2089
36. Stossi F, Madak-Erdogan Z, Katzenellenbogen BS (2012) Macrophage-elicited loss of estrogen receptor-[alpha] in breast cancer cells via involvement of MAPK and c-Jun at the ESR1 genomic locus. Oncogene 31(14):1825-1834
37. Harkonen PL, Vaananen HK (2006) Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators. Ann N Y Acad Sci 1089(1):218-227
38. Hammond MEH, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med 134(7):48-72
39. Iwamoto T, Booser D, Valero V, Murray JL, Koenig K, Esteva FJ, Ueno NT, Zhang J, Shi W, Qi Y, Matsuoka J, Yang EJ, Hortobagyi GN, Hatzis C, Symmans WF, Pusztai L (2012) Estrogen Receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1 % to 10 % ER-positive by immunohistochemistry. J Clin Oncol 30(7):729-734
40. Deyarmin B, Kane J, Valente A, Laar R, Gallagher C, Shriver C, Ellsworth R (2013) Effect of ASCO/CAP guidelines for determining ER status on molecular subtype. Ann Surg Oncol 20(1):87-93
41. Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66(2):605-612